Search Results

There are 6522 results for: content related to: Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study

  1. Abstracts (Continue in Part XXXV)

    Proceedings of the International Society for Magnetic Resonance in Medicine

    Volume 1998, Issue S1, 1998, Pages: 1701–1750,

    Version of Record online : 21 APR 2006, DOI: 10.1002/mrmp.22419980135

  2. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  3. You have free access to this content
    Magnetic resonance spectroscopy in anxiety disorders

    Acta Neuropsychiatrica

    Volume 20, Issue 2, April 2008, Pages: 56–71, Clarissa Trzesniak, David Araújo and José Alexandre S. Crippa

    Version of Record online : 19 MAR 2008, DOI: 10.1111/j.1601-5215.2008.00270.x

  4. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 343–353, Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer and Johannes Schwarz

    Version of Record online : 6 OCT 2005, DOI: 10.1002/mds.20724


    Developmental Medicine & Child Neurology

    Volume 37, Issue 5, May 1995, Pages: 398–405, Toshiaki Hashimoto, Masanobu Tayaina, Masahito Miyazaki, Emiko Fujii, Masafumi Harada, Hirukazu Miyoshi, Miki Tannuchi and Yasuhiro Kuroda

    Version of Record online : 12 NOV 2008, DOI: 10.1111/j.1469-8749.1995.tb12023.x

  6. Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction

    Journal of Veterinary Pharmacology and Therapeutics

    D. McFarlane, H. Banse, H. K. Knych and L. K. Maxwell

    Version of Record online : 15 JUN 2016, DOI: 10.1111/jvp.12339

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  8. Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis

    Muscle & Nerve

    Volume 47, Issue 1, January 2013, Pages: 61–67, Ken Ikeda, Kiyoko Murata, Yuji Kawase, Kiyokazu Kawabe, Osamu Kano, Yasuhiro Yoshii, Takanori Takazawa, Takehisa Hirayama and Yasuo Iwasaki

    Version of Record online : 5 OCT 2012, DOI: 10.1002/mus.23467

  9. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  10. Proton MRS in mild cognitive impairment

    Journal of Magnetic Resonance Imaging

    Volume 37, Issue 4, April 2013, Pages: 770–777, Kejal Kantarci

    Version of Record online : 22 MAR 2013, DOI: 10.1002/jmri.23800

  11. Proton Magnetic Resonance Spectroscopy as a Probe into the Pathophysiology of Autism Spectrum Disorders (ASD): A Review

    Autism Research

    Volume 6, Issue 2, April 2013, Pages: 119–133, Joshua M. Baruth, Christopher A. Wall, Marc C. Patterson and John D. Port

    Version of Record online : 21 FEB 2013, DOI: 10.1002/aur.1273

  12. Pergolide for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    C E Clarke and Julie Speller

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD000235

  13. You have free access to this content
    Poster Session 1

    European Journal of Neurology

    Volume 13, Issue s2, September 2006, Pages: 42–168,

    Version of Record online : 12 SEP 2006, DOI: 10.1111/j.1468-1331.2006.01621.x

  14. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 858–866, William Koller, Andrew Lees, Miroslava Doder, Mariese Hely and the Tolcapone/Pergolide Study Group

    Version of Record online : 20 SEP 2001, DOI: 10.1002/mds.1175

  15. Abstracts (Continue in Part I)

    Proceedings of the International Society for Magnetic Resonance in Medicine

    Volume 1994, Issue S2, 1994, Pages: 573–622,

    Version of Record online : 15 DEC 2005, DOI: 10.1002/mrmp.22419940202

  16. You have free access to this content
    Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies

    Journal of Neurochemistry

    Volume 128, Issue 1, January 2014, Pages: 1–87, Anne Schwerk, Fabiana D. S. Alves, Petra J. W. Pouwels and Therese van Amelsvoort

    Version of Record online : 30 SEP 2013, DOI: 10.1111/jnc.12398

  17. Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 276–280, Ashok Krishnaswami, Kathleen B. Albers, Robin D. Fross, James J. Jang, Sarah B. Berkheimer, Valerie C. Kwai Ben and Stephen K. VanDenEeden

    Version of Record online : 9 JAN 2012, DOI: 10.1002/pds.2274

  18. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study

    Autism Research

    Volume 9, Issue 6, June 2016, Pages: 643–657, Lauren E. Libero, Meredith A. Reid, David M. White, Nouha Salibi, Adrienne C. Lahti and Rajesh K. Kana

    Version of Record online : 3 NOV 2015, DOI: 10.1002/aur.1562

  19. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging

    Human Brain Mapping

    Volume 33, Issue 12, December 2012, Pages: 2971–2983, Michiel B. de Ruiter, Liesbeth Reneman, Willem Boogerd, Dick J. Veltman, Matthan Caan, Gwenaëlle Douaud, Cristina Lavini, Sabine C. Linn, Epie Boven, Frits S.A.M. van Dam and Sanne B. Schagen

    Version of Record online : 23 SEP 2011, DOI: 10.1002/hbm.21422

  20. You have free access to this content
    Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum

    Journal of Neurochemistry

    Volume 102, Issue 3, August 2007, Pages: 699–711, Evgeny Bychkov, M. Rafiuddin Ahmed, Kevin N. Dalby and Eugenia V. Gurevich

    Version of Record online : 21 MAR 2007, DOI: 10.1111/j.1471-4159.2007.04586.x